US20070125389A1 - Minimally light reflective surgical drape - Google Patents
Minimally light reflective surgical drape Download PDFInfo
- Publication number
- US20070125389A1 US20070125389A1 US11/672,824 US67282407A US2007125389A1 US 20070125389 A1 US20070125389 A1 US 20070125389A1 US 67282407 A US67282407 A US 67282407A US 2007125389 A1 US2007125389 A1 US 2007125389A1
- Authority
- US
- United States
- Prior art keywords
- surgical drape
- drape
- polymeric film
- light
- surgical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000004313 glare Effects 0.000 claims abstract description 21
- 208000003464 asthenopia Diseases 0.000 claims abstract description 19
- 238000002310 reflectometry Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- 229920000098 polyolefin Polymers 0.000 claims 1
- 239000003086 colorant Substances 0.000 abstract description 13
- 230000000116 mitigating effect Effects 0.000 abstract description 5
- 239000000975 dye Substances 0.000 abstract description 3
- 239000000049 pigment Substances 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 34
- 210000001508 eye Anatomy 0.000 description 25
- 239000000463 material Substances 0.000 description 22
- 210000003205 muscle Anatomy 0.000 description 8
- 230000004907 flux Effects 0.000 description 7
- 230000000007 visual effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 238000005286 illumination Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B46/00—Surgical drapes
- A61B46/40—Drape material, e.g. laminates; Manufacture thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B46/00—Surgical drapes
Definitions
- the present invention relates to surgical drapes, and more particularly to surgical drapes formed from a polymeric film having a low glare finish and a predetermined coloration for selectively reducing the luminous intensity of light reflected from the surface thereof.
- the complete visual system requires light, the eye, and a conscious observer.
- the visual system is especially well adapted for rapid and precise visual extraction of spatial information from a more or less remote external world, doing so by analysis of the continuously changing patterns of radiant flux impinging upon the surfaces of the eyes. Much of this light is reflected from objects which must be discriminated, recognized, attended to, and/or avoided in the environment, all the while transcending enormous variations in intensity, quality and geometry of illumination as well as the vantage point of the observer.
- Light i.e., visible light
- the lighting or illumination of a surface is the luminous flux which it receives per unit area (i.e., luminous flux is a measure of the power of visible light).
- Common units for luminous flux include the foot-candle (i.e., 1 lumen per square foot, or the foot lambert), and the lux (i.e., 1 lumen per square meter).
- Minimum recommended task based lighting levels are provided by General Electric Company as follows: casual, 30 footcandles (fc); rough, 50 fc; medium, 100 fc; fine, 500 fc; and, extra-fine, 1,000 fc.
- Color is a characteristic of light that produces specific degrees of hue, saturation and brightness, with most color models of perceived color containing these three components. For instance, in the International Commission on Illumination (CIE) “L*a*b model”, color is modeled as a sphere, with lightness comprising the linear transformation from white to black, and hues modeled as opposing pairs, with saturation being the distance from the lightness axis.
- CIE International Commission on Illumination
- Chromaticity i.e., apparent color temperature or correlated color temperature
- incandescence i.e., the point of emitting light
- Selected sources of illumination and their color temperatures include: candle flame, 1850° K; sunlight (sunrise/set), 2000° K; sunlight (mean noon), 5400° K; 40 watt incandescent tungsten lamp, 2650° K; 100 watt incandescent tungsten lamp, 2865° K; 500 watt incandescent tungsten lamp, 2960° K; photoflood/reflector flood, 3400° K; white flame carbon arc lamp, 5000° K; and, xenon arc lamp, 6420° K.
- the human eye includes various muscles which, like any part of the human body, will tire and strain when kept in a fixed configuration for sufficiently long periods. Immediate symptoms of eye fatigue and eye strain include headaches and difficulty focusing one's vision. In the long term, prolonged or severe eye fatigue and strain may decrease the strength of eye muscles and require corrective lenses, or an increased prescription for those already requiring corrective lenses.
- a viewer's eyes must focus in order to properly perceive an object. Focusing causes strain to the viewer's eyes.
- the eye's lens thickens. That is, the closer an object to the viewer, the thicker the eye's lens must shape themselves. Thickening the eye's lens is particularly exhausting on the eye muscles, serving to exacerbate the fatigue and strain brought on by the convergence that also accompanies viewing close objects.
- Some of the most common causes of eye fatigue and/or strain include viewing close objects, viewing objects displayed on a light emitting medium, and simply viewing images for excessive time periods. Reading or doing close work in extreme light conditions, whether bright or dim, for extended periods forces the eyes to focus under less than optimal conditions, and thereby contributes to eye strain, symptoms of which may include; headaches; blurred vision; pain or soreness of the eyeball; red/watery eyes; dry eyes that feel scratchy; tired, aching heaviness of the eyelids or forehead; back and neck aches; and, muscle spasms.
- Glare is a similar phenomenon which contributes to eye strain, in addition to mitigating visual acuity.
- the contrast between the image being viewed and its background is reduced by reflected light, making it harder for the brain to interpret the image. Facial and eye muscles tighten as the eye unconsciously strains to send a clear signal to the brain.
- a particularly harsh visual system setting, or environment, for the eyes is a hospital operating room.
- high intensity surgical lighting systems are present to aid the surgeon and his or her team.
- Such lighting systems are known to deliver up to, and in excess of 140,000 lux (i.e., lumens per square meter, or about 13,000 fc) at about 4500° K chromaticity.
- Working for long periods of time, anywhere from one to eight plus hours per procedure, under such light conditions is more often than not the cause of eye fatigue and/or strain. Alleviation or mitigation of the source of such stress to the visual system would be most welcome.
- Such improved working conditions, as minimal as they might seem, may be of paramount importance to those who rely upon the skill and execution of the surgeon.
- a surgical drape manufactured or fabricated from a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof is provided.
- Such surgical drape thereby minimizes reflectivity therefrom, and thus eye strain and fatigue.
- the subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light.
- the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a surgical drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue.
- the preferred range of reflected light in order of preference, is 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm. More specific features and advantages will become apparent with reference to the DETAILED DESCRIPTION OF THE INVENTION, appended claims, and the accompanying drawing figures.
- FIG. 1 is a plan view of a surgical drape of the subject invention, more particularly an ocular drape;
- FIG. 2 is a side or edge view of the surgical drape of FIG. 1 ;
- FIG. 3 is a tabulation of Test No. 1 data, namely average gloss values, as a function of geometry, for each of the test drape samples;
- FIG. 4 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table of FIG. 3 ;
- FIG. 5 is a tabulation of Test No. 2 data, namely average gloss values, as a function of geometry, for each of the test drape samples;
- FIG. 6 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table of FIG. 5 ;
- FIG. 7 is a tabular summary of statistical parameters associated with the obtained gloss data
- FIG. 8 is a tabular comparison of t-Test results for the drape of the subject invention and the benchmark drape;
- FIG. 9 is a graph depicting the average (mean) gloss values at an 95% confidence interval recorded for each of the test drape samples of the table of FIG. 7 ;
- FIG. 10 is a graph depicting the standard deviation of the gloss values recorded for each of the test drape samples of the table of FIG. 7 ;
- FIG. 11 is a tabulation of luminance, as a function of drape finish, for each of the test drape samples.
- FIG. 12 is a graphic representation of the data of FIG. 11 .
- FIGS. 1 and 2 there is shown a surgical drape 10 , more particularly an ophthalmic incise drape, having a perimeter edge 12 , an adhesive patch 14 , and a drain port assembly 16 .
- a surgical drape 10 more particularly an ophthalmic incise drape, having a perimeter edge 12 , an adhesive patch 14 , and a drain port assembly 16 .
- ophthalmic drape is shown, it is to be understood that the present invention is not so limited, with any drape style or configuration being formed, treated, otherwise manufactured, etc., as is known to those of skill in the pertinent art, so as to reduce eye strain consistent with the invention of the subject disclosure.
- Drape styles suitable for the practice of the subject invention include, but are not limited to, those disclosed in U.S. Pat. Nos. 4,745,915 and 6,102,044, each of which being incorporated herein by reference.
- the subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. Furthermore, the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. Test results, which are discussed hereinafter, indicate that the preferred range of reflected light be, in order of preference, 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm.
- Colored drape line testing was conducted to demonstrate the reduction in both glare and light reflection utilizing the colored polyethylene surgical drapes. Both specular gloss testing, illuminance, and chromaticity testing was completed. A discussion of each methodology and the results obtained follows.
- Specular gloss testing was performed in accordance with ASTM Standard D523-89, which is incorporated herein by reference, on differing polyethylene drape materials.
- a specular gloss test measures the capacity of a surface to reflect more light in one direction than in others. The main factors that affect the reflection of light from a surface are the haziness of the material and the texture of the surface.
- the specular gloss test is performed using an apparatus that consists of an incandescent light source and a photo detector. The angle of the incident light is measured from the perpendicular of the material surface. The photo detector is placed at the mirror/image position of the light source. Measurements of the luminous flux are taken at 85°, 60°, and 20° geometries. The values that are obtained from the measurements are the relative luminous reflectance factor (RLRF).
- the RLRF is the ratio of the luminous flux from the surface being tested to the luminous flux of a standard polished glass mounted on a black surface measured at the same angle.
- the results from this test are mainly affected by the surface finish of material, it is expected that the difference between specular gloss readings for the benchmark drapes (i.e., a Minnesota Mining & Manufacturing, Inc. model No. 1060 (hereinafter 3M® 1060), and a Medical Concepts Design Inc., model No. D1060 (hereinafter MCD D1060)) to be greater than the difference between the colored drape materials.
- 3M® 1060 Minnesota Mining & Manufacturing, Inc. model No. 1060
- MCD D1060 Medical Concepts Design Inc.
- Test No. 1 In a first study (i.e., Test No. 1), nine different drape samples were tested, and ten readings were taken for each drape sample. The results of the testing are presented in FIGS. 3 and 4 .
- Section 4 of ASTM D523 indicates that an 85° geometry is the most useful for comparing different specimens when the gloss value at 60° is less than 10.
- the graph of FIG. 4 shows the average gloss values for each specimen at a 85° geometry.
- the graph of FIG. 4 also has standard deviation bars of ⁇ centered on the average value. From this graph, it can be seen that the benchmark MCD D1060 drape and the colored drapes, which have a similar surface texture, are all within a narrow range of values (1.7-3.8).
- the benchmark 3M® 1060 drape is outside the aforementioned range (5.6), indicating that its gloss value was significantly higher than that of the benchmark MCD D1060 drape.
- a second specular gloss study (i.e., Test No. 2) was performed using those drape colors which yielded the lowest average gloss value in the first study. Also included were the benchmark MCD D1060 and the benchmark 3M® 1060 drape for comparison. In the second study, two different samples of each drape material were tested and the measurements were all taken on the matte finish side. The results are presented in FIGS. 5 and 6 .
- the graph of FIG. 6 shows the average gloss values for each specimen at a 85° geometry.
- the graph of FIG. 6 also has standard deviation bars of ⁇ centered on the average value. From this graph, it can be seen that there is little difference between the benchmark MCD D1060 drape material and the colored drape material. Once again, these materials have very similar surface texture. It is further clear from the graph of FIG. 6 that the gross values for the benchmark 3M® 1060 drape samples are higher than those of the benchmark MCD D1060 drape and colored drapes. Both samples of the benchmark 3M® 1060 drape have the same average gloss value (i.e., 4.9).
- the average gloss values for the samples of the benchmark MCD D1060 drape and colored drape materials are between 1.7 and 2.6.
- the clear MCD drape samples have values at both extremes of this range, and all the gloss values for the colored drapes fell between these two extremes, indicating that color was not a factor. Since the main difference between all of these materials is surface texture, it is apparent that the rougher (i.e., less smooth) surface finishes of the MCD D1060 and the colored drape materials reduce glare significantly when compared to the benchmark 3M® 1060. There seems to be no correlation between the color of the drape material and glare reduction since the gloss value difference between the benchmark MCD D1060 clear drape and the colored drapes is not very significant.
- Results of a statistical analysis of gloss data are generally presented in FIGS. 7-10 . Values for tabulated statistical parameters are found in FIG. 7 , tabulated t-Test results for the MCD D1060 and 3M® 1060 drapes are found in FIG. 8 ., with mean and standard deviation gloss readings for noted test articles illustrated in FIGS. 9 and 10 respectively.
- luminance value i.e., a measurement of luminous intensity of light being reflected from the surface of the material in a given direction per unit area of projected area of the source, as viewed from that direction.
- the results of this test indicate that there is a difference between the different drape material colors when it comes to the amount of light reflected.
- the wide standard deviation bars ( ⁇ centered about the average value calculated from the data point on the graph) indicate this large difference.
- the highest value was for the benchmark 3M® 1060 drape. It had luminance values of 6,675 foot lambert (fL) on the matte side and 6,528 fL on the non-matte side.
- the benchmark MCD D1060 drape was also above the 6,000 fL value.
- the colored drape line testing indicates that the surface finish of the film has the greatest effect on glare.
- the rougher the surface finish the less glare.
- Color has very negligible effect on glare.
- the color of the film has the greatest effect on the reduction of the intensity of the light reflected from the film surface.
- the colors in the middle of the visible spectrum did not perform as well, with the two white colored benchmark drapes being the least effective.
- the surface finish of the film had no effect on the amount of light reflected.
- the color of the film controls the intensity of the light reflected
- surface finish of the film controls the glare.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Eyeglasses (AREA)
- Cosmetics (AREA)
Abstract
A surgical drape manufactured or fabricated from a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof is provided. Such surgical drape thereby minimizes reflectivity therefrom, and thus eye strain and fatigue. The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. More particularly, the use of coloring agents in combination with a textured surface yield a surgical drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. The preferred range of reflected light, in order of preference, is 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm.
Description
- The present invention relates to surgical drapes, and more particularly to surgical drapes formed from a polymeric film having a low glare finish and a predetermined coloration for selectively reducing the luminous intensity of light reflected from the surface thereof.
- The complete visual system requires light, the eye, and a conscious observer. The visual system is especially well adapted for rapid and precise visual extraction of spatial information from a more or less remote external world, doing so by analysis of the continuously changing patterns of radiant flux impinging upon the surfaces of the eyes. Much of this light is reflected from objects which must be discriminated, recognized, attended to, and/or avoided in the environment, all the while transcending enormous variations in intensity, quality and geometry of illumination as well as the vantage point of the observer.
- Light (i.e., visible light) represents only one portion of the electromagnetic spectrum, namely the portion laying between radio waves and x-rays, more particularly those electromagnetic waves possessing a wavelength between about 380-770 nanometers (nm). The lighting or illumination of a surface is the luminous flux which it receives per unit area (i.e., luminous flux is a measure of the power of visible light). Common units for luminous flux (i.e., illuminance) include the foot-candle (i.e., 1 lumen per square foot, or the foot lambert), and the lux (i.e., 1 lumen per square meter). Minimum recommended task based lighting levels are provided by General Electric Company as follows: casual, 30 footcandles (fc); rough, 50 fc; medium, 100 fc; fine, 500 fc; and, extra-fine, 1,000 fc.
- Color is a characteristic of light that produces specific degrees of hue, saturation and brightness, with most color models of perceived color containing these three components. For instance, in the International Commission on Illumination (CIE) “L*a*b model”, color is modeled as a sphere, with lightness comprising the linear transformation from white to black, and hues modeled as opposing pairs, with saturation being the distance from the lightness axis.
- Chromaticity (i.e., apparent color temperature or correlated color temperature) is the measure of a light source's “warmth” or “coolness,” expressed in the Kelvin (° K) temperature scale. It describes the appearance an object would have if it were heated to incandescence (i.e., the point of emitting light) then to higher temperatures where the appearance changes from ruddy red through a range of warm colors to white, then finally to blue-white. Selected sources of illumination and their color temperatures include: candle flame, 1850° K; sunlight (sunrise/set), 2000° K; sunlight (mean noon), 5400° K; 40 watt incandescent tungsten lamp, 2650° K; 100 watt incandescent tungsten lamp, 2865° K; 500 watt incandescent tungsten lamp, 2960° K; photoflood/reflector flood, 3400° K; white flame carbon arc lamp, 5000° K; and, xenon arc lamp, 6420° K.
- The human eye includes various muscles which, like any part of the human body, will tire and strain when kept in a fixed configuration for sufficiently long periods. Immediate symptoms of eye fatigue and eye strain include headaches and difficulty focusing one's vision. In the long term, prolonged or severe eye fatigue and strain may decrease the strength of eye muscles and require corrective lenses, or an increased prescription for those already requiring corrective lenses.
- When an object is too close to a viewer, the viewer is forced to bring his or her eyes inward (i.e., towards their nose). The motion of the eyes turning inward is called convergence. Convergence requires intensive exertion of the eye muscles, in particular the ocular muscles. When the eyes are not properly relaxed through either visual exercise or rest, the viewer may experience eye fatigue and/or eye strain. Repeated and/or prolonged convergence can permanently decrease the strength of the eye muscles.
- In addition, a viewer's eyes must focus in order to properly perceive an object. Focusing causes strain to the viewer's eyes. In order to focus on close objects, the eye's lens thickens. That is, the closer an object to the viewer, the thicker the eye's lens must shape themselves. Thickening the eye's lens is particularly exhausting on the eye muscles, serving to exacerbate the fatigue and strain brought on by the convergence that also accompanies viewing close objects.
- One result of eye fatigue and eye strain is a diminished synchronization between a viewer's pair of eyes. That is, the viewer's left and right eyes are not working synchronously to provide the visual information required to visually perceive one's surroundings. Accordingly, common orthoptic tests involve monitoring the eye's ability to synchronize, while common orthoptic treatments involve the viewer performing eye exercises that promote synchronization, either through stretching and strengthening the eye muscles, or via forced relaxation.
- Some of the most common causes of eye fatigue and/or strain include viewing close objects, viewing objects displayed on a light emitting medium, and simply viewing images for excessive time periods. Reading or doing close work in extreme light conditions, whether bright or dim, for extended periods forces the eyes to focus under less than optimal conditions, and thereby contributes to eye strain, symptoms of which may include; headaches; blurred vision; pain or soreness of the eyeball; red/watery eyes; dry eyes that feel scratchy; tired, aching heaviness of the eyelids or forehead; back and neck aches; and, muscle spasms.
- Glare is a similar phenomenon which contributes to eye strain, in addition to mitigating visual acuity. The contrast between the image being viewed and its background is reduced by reflected light, making it harder for the brain to interpret the image. Facial and eye muscles tighten as the eye unconsciously strains to send a clear signal to the brain.
- A particularly harsh visual system setting, or environment, for the eyes is a hospital operating room. In addition to the requirements of up-close high precision work, which in and of itself is stressful, high intensity surgical lighting systems are present to aid the surgeon and his or her team. Such lighting systems are known to deliver up to, and in excess of 140,000 lux (i.e., lumens per square meter, or about 13,000 fc) at about 4500° K chromaticity. Working for long periods of time, anywhere from one to eight plus hours per procedure, under such light conditions is more often than not the cause of eye fatigue and/or strain. Alleviation or mitigation of the source of such stress to the visual system would be most welcome. Such improved working conditions, as minimal as they might seem, may be of paramount importance to those who rely upon the skill and execution of the surgeon.
- A surgical drape manufactured or fabricated from a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof is provided. Such surgical drape thereby minimizes reflectivity therefrom, and thus eye strain and fatigue. The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. Furthermore, the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a surgical drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. The preferred range of reflected light, in order of preference, is 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm. More specific features and advantages will become apparent with reference to the DETAILED DESCRIPTION OF THE INVENTION, appended claims, and the accompanying drawing figures.
-
FIG. 1 is a plan view of a surgical drape of the subject invention, more particularly an ocular drape; -
FIG. 2 is a side or edge view of the surgical drape ofFIG. 1 ; -
FIG. 3 is a tabulation of Test No. 1 data, namely average gloss values, as a function of geometry, for each of the test drape samples; -
FIG. 4 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table ofFIG. 3 ; -
FIG. 5 is a tabulation of Test No. 2 data, namely average gloss values, as a function of geometry, for each of the test drape samples; -
FIG. 6 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table ofFIG. 5 ; -
FIG. 7 is a tabular summary of statistical parameters associated with the obtained gloss data; -
FIG. 8 is a tabular comparison of t-Test results for the drape of the subject invention and the benchmark drape; -
FIG. 9 is a graph depicting the average (mean) gloss values at an 95% confidence interval recorded for each of the test drape samples of the table ofFIG. 7 ; -
FIG. 10 is a graph depicting the standard deviation of the gloss values recorded for each of the test drape samples of the table ofFIG. 7 ; -
FIG. 11 is a tabulation of luminance, as a function of drape finish, for each of the test drape samples; and, -
FIG. 12 is a graphic representation of the data ofFIG. 11 . - Referring to
FIGS. 1 and 2 , there is shown asurgical drape 10, more particularly an ophthalmic incise drape, having aperimeter edge 12, anadhesive patch 14, and adrain port assembly 16. These figures are provided to illustrate one embodiment of the subject invention. Although an ophthalmic drape is shown, it is to be understood that the present invention is not so limited, with any drape style or configuration being formed, treated, otherwise manufactured, etc., as is known to those of skill in the pertinent art, so as to reduce eye strain consistent with the invention of the subject disclosure. Drape styles suitable for the practice of the subject invention include, but are not limited to, those disclosed in U.S. Pat. Nos. 4,745,915 and 6,102,044, each of which being incorporated herein by reference. - The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. Furthermore, the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. Test results, which are discussed hereinafter, indicate that the preferred range of reflected light be, in order of preference, 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm.
- Colored drape line testing was conducted to demonstrate the reduction in both glare and light reflection utilizing the colored polyethylene surgical drapes. Both specular gloss testing, illuminance, and chromaticity testing was completed. A discussion of each methodology and the results obtained follows.
- Specular Gloss Testing
- Specular gloss testing was performed in accordance with ASTM Standard D523-89, which is incorporated herein by reference, on differing polyethylene drape materials. A specular gloss test measures the capacity of a surface to reflect more light in one direction than in others. The main factors that affect the reflection of light from a surface are the haziness of the material and the texture of the surface. The specular gloss test is performed using an apparatus that consists of an incandescent light source and a photo detector. The angle of the incident light is measured from the perpendicular of the material surface. The photo detector is placed at the mirror/image position of the light source. Measurements of the luminous flux are taken at 85°, 60°, and 20° geometries. The values that are obtained from the measurements are the relative luminous reflectance factor (RLRF). The RLRF is the ratio of the luminous flux from the surface being tested to the luminous flux of a standard polished glass mounted on a black surface measured at the same angle.
- Since the results from this test are mainly affected by the surface finish of material, it is expected that the difference between specular gloss readings for the benchmark drapes (i.e., a Minnesota Mining & Manufacturing, Inc. model No. 1060 (hereinafter 3M® 1060), and a Medical Concepts Design Inc., model No. D1060 (hereinafter MCD D1060)) to be greater than the difference between the colored drape materials. This is primarily due to the fact that the surface finish of the benchmark drapes are different. The difference in the specular gloss readings between the colored drapes and the MCD D1060 drape should not be as great since they have a similar surface finish. The MCD D1060 drape and the colored drape should have lower specular gloss numbers since, when observed visually, they appear to have much less glare than the
3M® 1060 drape. - In a first study (i.e., Test No. 1), nine different drape samples were tested, and ten readings were taken for each drape sample. The results of the testing are presented in
FIGS. 3 and 4 . -
Section 4 of ASTM D523 indicates that an 85° geometry is the most useful for comparing different specimens when the gloss value at 60° is less than 10. The graph ofFIG. 4 shows the average gloss values for each specimen at a 85° geometry. The graph ofFIG. 4 also has standard deviation bars of ±σ centered on the average value. From this graph, it can be seen that the benchmark MCD D1060 drape and the colored drapes, which have a similar surface texture, are all within a narrow range of values (1.7-3.8). Thebenchmark 3M® 1060 drape is outside the aforementioned range (5.6), indicating that its gloss value was significantly higher than that of the benchmark MCD D1060 drape. - A second specular gloss study (i.e., Test No. 2) was performed using those drape colors which yielded the lowest average gloss value in the first study. Also included were the benchmark MCD D1060 and the
benchmark 3M® 1060 drape for comparison. In the second study, two different samples of each drape material were tested and the measurements were all taken on the matte finish side. The results are presented inFIGS. 5 and 6 . - Once again, the values of the 600 geometry were below 10, so the 85° geometry values were used for the comparison purposes. The graph of
FIG. 6 shows the average gloss values for each specimen at a 85° geometry. The graph ofFIG. 6 also has standard deviation bars of ±σ centered on the average value. From this graph, it can be seen that there is little difference between the benchmark MCD D1060 drape material and the colored drape material. Once again, these materials have very similar surface texture. It is further clear from the graph ofFIG. 6 that the gross values for thebenchmark 3M® 1060 drape samples are higher than those of the benchmark MCD D1060 drape and colored drapes. Both samples of thebenchmark 3M® 1060 drape have the same average gloss value (i.e., 4.9). The average gloss values for the samples of the benchmark MCD D1060 drape and colored drape materials are between 1.7 and 2.6. The clear MCD drape samples have values at both extremes of this range, and all the gloss values for the colored drapes fell between these two extremes, indicating that color was not a factor. Since the main difference between all of these materials is surface texture, it is apparent that the rougher (i.e., less smooth) surface finishes of the MCD D1060 and the colored drape materials reduce glare significantly when compared to thebenchmark 3M® 1060. There seems to be no correlation between the color of the drape material and glare reduction since the gloss value difference between the benchmark MCD D1060 clear drape and the colored drapes is not very significant. - Results of a statistical analysis of gloss data are generally presented in
FIGS. 7-10 . Values for tabulated statistical parameters are found inFIG. 7 , tabulated t-Test results for the MCD D1060 and3M® 1060 drapes are found inFIG. 8 ., with mean and standard deviation gloss readings for noted test articles illustrated inFIGS. 9 and 10 respectively. - Illuminance and Chromaticity Testing
- Illuminance and chromaticity testing was performed to measure the differences between the colored and clear drape materials. The illuminance test measures the amount of light that was reflected from the drapes' surface. The chromaticity test measures the hue and saturation of the light reflected from the surface. The tests were performed on the matte and non-matte finished sides of the drape materials. The test was performed using a PR-703 photo research spectra radiometer. The samples were placed in the same standard surface and a xenon light source was used to illuminate the material. The light source was perpendicular to the surface of the material. The detector was at a 10° angle from the light beam since it could not physically occupy the same space as the light source.
- As the objective of the illuminance and chromaticity testing is to find the material colors that most reduce the intensity of reflected light, determination of luminance value (i.e., a measurement of luminous intensity of light being reflected from the surface of the material in a given direction per unit area of projected area of the source, as viewed from that direction) is critical. The results of the illuminance test are presented in
FIGS. 11 and 12 . - The results of this test indicate that there is a difference between the different drape material colors when it comes to the amount of light reflected. The wide standard deviation bars (±σ centered about the average value calculated from the data point on the graph) indicate this large difference. The highest value was for the
benchmark 3M® 1060 drape. It had luminance values of 6,675 foot lambert (fL) on the matte side and 6,528 fL on the non-matte side. The benchmark MCD D1060 drape was also above the 6,000 fL value. The lowest values were associated with films colored red, dark blue, and purple (i.e., violet), with their luminance values ranging from 3,637 to 3,908 fL for the matte finish side of the film, and 3,624 to 3,790 fL for the non-matte side of the film. They were substantially lower than all other film colorations. From this information it is concluded that the intensity of the light reflected was lowest for the dark colors, and highest for the two benchmark drapes. This test also supports the notion that the color of the drape material plays a much great role in the intensity of the reflected light. The finish of the film has minimal effect on the intensity of reflected light, as shown by the very close values associated with the matte and non-matte finish sides of each of the films. On the graph ofFIG. 12 , the standard deviation bars of ±σ centered on the average value of all the data points for the matte and non-matte finish sides are indicated. The average for both is almost the same, and the standard deviation for both almost identical, indicating that the surface finish of the film does not affect the intensity of the reflected light. - The colored drape line testing indicates that the surface finish of the film has the greatest effect on glare. The rougher the surface finish, the less glare. Color has very negligible effect on glare. Furthermore, the color of the film has the greatest effect on the reduction of the intensity of the light reflected from the film surface. The darker colors, towards the red and violet ends of the spectrum, performed best. The colors in the middle of the visible spectrum did not perform as well, with the two white colored benchmark drapes being the least effective. The surface finish of the film had no effect on the amount of light reflected. In summary, the color of the film controls the intensity of the light reflected, and surface finish of the film controls the glare.
- It will be understood that this disclosure, in many respects, is only illustrative. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims.
Claims (16)
1. A surgical drape comprising a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof, said surgical drape thereby minimizing reflectivity and potential eye strain.
2. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 4,000 to 4,500 angstroms.
3. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 4,500 to 5,200 angstroms.
4. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 5,200 to 5,600 angstroms.
5. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 6,250 to 7,000 angstroms.
6. The surgical drape of claim 1 wherein said low glare finish is a matted surface.
7. The surgical drape of claim 1 wherein said low glare finish is a textured surface.
8. The surgical drape of claim 1 wherein said luminous intensity is reduced by up to about 45%.
9. The surgical drape of claim 1 wherein said polymeric film comprises a polyolefin.
10. The surgical drape of claim 1 further comprising a coating of an adhesive composition overlying at least a portion of said polymeric film.
11. The surgical drape of claim 10 further comprising a release liner, said release liner overlaying said coating of an adhesive composition for selective removal therefrom.
12. The surgical drape of claim 11 further comprising an antimicrobial agent carried by said polymeric film, said antimicrobial agent being carried by said polymeric film on a side opposite said coating of an adhesive composition.
13. In a method of producing a surgical drape, the steps comprising:
(a) selectively adding coloration to a polymeric drape starting material;
(c) forming a surgical drape from the colored polymeric drape starting material so as to produce a translucent, energy absorbing polymeric surgical drape capable of reducing the luminous intensity of light being reflected from the surface thereof, thereby substantially eliminating eye strain.
14. In the method of claim 13 , the further step of providing a low glare finish to at least one side of said translucent, energy absorbing polymeric surgical drape.
15. In the method of claim 14 wherein said low glare finish is a matted surface.
16. In the method of claim 14 wherein said low glare finish is a textured surface.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/672,824 US20070125389A1 (en) | 2001-10-10 | 2007-02-08 | Minimally light reflective surgical drape |
US11/752,107 US20080078413A1 (en) | 1996-06-12 | 2007-05-22 | Surgical drape |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/975,646 US6530376B1 (en) | 2001-10-10 | 2001-10-10 | Minimally light reflective surgical drape |
US10/385,981 US20040003818A1 (en) | 2001-10-10 | 2003-03-10 | Minimally light reflective surgical drape |
US11/672,824 US20070125389A1 (en) | 2001-10-10 | 2007-02-08 | Minimally light reflective surgical drape |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/385,981 Continuation US20040003818A1 (en) | 1996-06-12 | 2003-03-10 | Minimally light reflective surgical drape |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/752,107 Continuation-In-Part US20080078413A1 (en) | 1996-06-12 | 2007-05-22 | Surgical drape |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070125389A1 true US20070125389A1 (en) | 2007-06-07 |
Family
ID=25523245
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/975,646 Expired - Lifetime US6530376B1 (en) | 1996-06-12 | 2001-10-10 | Minimally light reflective surgical drape |
US10/385,981 Abandoned US20040003818A1 (en) | 1996-06-12 | 2003-03-10 | Minimally light reflective surgical drape |
US11/672,824 Abandoned US20070125389A1 (en) | 1996-06-12 | 2007-02-08 | Minimally light reflective surgical drape |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/975,646 Expired - Lifetime US6530376B1 (en) | 1996-06-12 | 2001-10-10 | Minimally light reflective surgical drape |
US10/385,981 Abandoned US20040003818A1 (en) | 1996-06-12 | 2003-03-10 | Minimally light reflective surgical drape |
Country Status (7)
Country | Link |
---|---|
US (3) | US6530376B1 (en) |
JP (2) | JP4511781B2 (en) |
AU (1) | AU2002301402B2 (en) |
CA (1) | CA2407216A1 (en) |
IL (1) | IL152191A (en) |
NZ (1) | NZ521897A (en) |
ZA (1) | ZA200208173B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6530376B1 (en) * | 2001-10-10 | 2003-03-11 | Medical Concepts Development, Inc. | Minimally light reflective surgical drape |
AU2002233103B2 (en) * | 2001-03-02 | 2006-11-02 | Woodwelding Ag | Implants, device and method for joining tissue parts |
US7290547B2 (en) * | 2003-12-01 | 2007-11-06 | Joseph Hare | Covering for an aseptic treatment site |
US7275544B2 (en) * | 2003-12-01 | 2007-10-02 | Michael Gil | Covering for an aseptic treatment site |
US20100180901A1 (en) * | 2005-03-25 | 2010-07-22 | Myers Thomas H | Conformable drape system |
JP5055276B2 (en) * | 2005-07-20 | 2012-10-24 | オプティマス ライセンシング アクチェンゲゼルシャフト | Hospital operating room lighting apparatus and method of using operating room light |
US10639118B2 (en) | 2011-04-06 | 2020-05-05 | Entrotech Life Sciences, Inc. | Surgical incise drapes and methods for their application |
EP3895651A1 (en) * | 2020-04-17 | 2021-10-20 | Hexis | Elastomer thermoplastic antimicrobial film, composition and manufacturing method for obtaining same |
FR3109387B1 (en) * | 2020-04-17 | 2023-11-10 | Hexis | Thermoplastic elastomeric antimicrobial film, composition and manufacturing process for obtaining it |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3589365A (en) * | 1969-08-28 | 1971-06-29 | Parke Davis & Co | Underbuttocks drape |
US3668050A (en) * | 1970-03-09 | 1972-06-06 | Kimberly Clark Co | Surgical drape |
US3669106A (en) * | 1970-07-27 | 1972-06-13 | Kimberly Clark Co | Surgical drape with adhesive attachment means |
US3677266A (en) * | 1970-12-31 | 1972-07-18 | Kimberly Clark Co | Gauze section for a surgical drape sheet |
US3763857A (en) * | 1972-04-24 | 1973-10-09 | Kimberly Clark Co | Surgical drape |
US4196245A (en) * | 1978-06-16 | 1980-04-01 | Buckeye Cellulos Corporation | Composite nonwoven fabric comprising adjacent microfine fibers in layers |
US4408996A (en) * | 1981-10-09 | 1983-10-11 | Burlington Industries, Inc. | Process for dyeing absorbent microbiocidal fabric and product so produced |
US5069907A (en) * | 1990-03-23 | 1991-12-03 | Phoenix Medical Technology | Surgical drape having incorporated therein a broad spectrum antimicrobial agent |
US5225236A (en) * | 1989-06-28 | 1993-07-06 | Preston Keusch | Composite protective drapes |
US5503076A (en) * | 1993-12-01 | 1996-04-02 | Kimberly-Clark Corporation | Multi-color printed nonwoven laminates |
US5985395A (en) * | 1996-05-16 | 1999-11-16 | 3M Innovative Properties Company | Surgical incise drape |
US6165625A (en) * | 1996-12-19 | 2000-12-26 | Kimberly-Clark Worldwide, Inc. | Method of making high intensity light resistant instrument pads |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3221649B2 (en) * | 1995-09-18 | 2001-10-22 | ユニチカ株式会社 | Medical laminated fabric |
US6530376B1 (en) * | 2001-10-10 | 2003-03-11 | Medical Concepts Development, Inc. | Minimally light reflective surgical drape |
US6245697B1 (en) * | 1998-11-12 | 2001-06-12 | The Procter & Gamble Company | Flexible mat for absorbing liquids comprising polymeric foam materials |
JP4364344B2 (en) * | 1999-05-10 | 2009-11-18 | ユニチカ株式会社 | Medical laminated fabric |
US6638605B1 (en) * | 1999-11-16 | 2003-10-28 | Allegiance Corporation | Intermittently bonded nonwoven disposable surgical laminates |
ATE282388T1 (en) * | 2000-01-31 | 2004-12-15 | Bki Holding Corp | ABSORBENT ARTICLE WITH IMPROVED VERTICAL WICKING AND REMOISTURE PROPERTIES |
-
2001
- 2001-10-10 US US09/975,646 patent/US6530376B1/en not_active Expired - Lifetime
-
2002
- 2002-10-09 CA CA002407216A patent/CA2407216A1/en not_active Abandoned
- 2002-10-09 AU AU2002301402A patent/AU2002301402B2/en not_active Ceased
- 2002-10-09 IL IL152191A patent/IL152191A/en not_active IP Right Cessation
- 2002-10-10 NZ NZ521897A patent/NZ521897A/en not_active IP Right Cessation
- 2002-10-10 JP JP2002297390A patent/JP4511781B2/en not_active Expired - Fee Related
- 2002-10-10 ZA ZA200208173A patent/ZA200208173B/en unknown
-
2003
- 2003-03-10 US US10/385,981 patent/US20040003818A1/en not_active Abandoned
-
2007
- 2007-02-08 US US11/672,824 patent/US20070125389A1/en not_active Abandoned
-
2009
- 2009-09-18 JP JP2009217501A patent/JP2010022841A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3589365A (en) * | 1969-08-28 | 1971-06-29 | Parke Davis & Co | Underbuttocks drape |
US3668050A (en) * | 1970-03-09 | 1972-06-06 | Kimberly Clark Co | Surgical drape |
US3669106A (en) * | 1970-07-27 | 1972-06-13 | Kimberly Clark Co | Surgical drape with adhesive attachment means |
US3677266A (en) * | 1970-12-31 | 1972-07-18 | Kimberly Clark Co | Gauze section for a surgical drape sheet |
US3763857A (en) * | 1972-04-24 | 1973-10-09 | Kimberly Clark Co | Surgical drape |
US4196245A (en) * | 1978-06-16 | 1980-04-01 | Buckeye Cellulos Corporation | Composite nonwoven fabric comprising adjacent microfine fibers in layers |
US4408996A (en) * | 1981-10-09 | 1983-10-11 | Burlington Industries, Inc. | Process for dyeing absorbent microbiocidal fabric and product so produced |
US5225236A (en) * | 1989-06-28 | 1993-07-06 | Preston Keusch | Composite protective drapes |
US5069907A (en) * | 1990-03-23 | 1991-12-03 | Phoenix Medical Technology | Surgical drape having incorporated therein a broad spectrum antimicrobial agent |
US5503076A (en) * | 1993-12-01 | 1996-04-02 | Kimberly-Clark Corporation | Multi-color printed nonwoven laminates |
US5985395A (en) * | 1996-05-16 | 1999-11-16 | 3M Innovative Properties Company | Surgical incise drape |
US6165625A (en) * | 1996-12-19 | 2000-12-26 | Kimberly-Clark Worldwide, Inc. | Method of making high intensity light resistant instrument pads |
Also Published As
Publication number | Publication date |
---|---|
US6530376B1 (en) | 2003-03-11 |
AU2002301402B2 (en) | 2009-06-11 |
CA2407216A1 (en) | 2003-04-10 |
US20040003818A1 (en) | 2004-01-08 |
IL152191A (en) | 2007-10-31 |
ZA200208173B (en) | 2003-10-23 |
NZ521897A (en) | 2004-04-30 |
IL152191A0 (en) | 2003-05-29 |
JP2010022841A (en) | 2010-02-04 |
JP4511781B2 (en) | 2010-07-28 |
JP2003199769A (en) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070125389A1 (en) | Minimally light reflective surgical drape | |
US6641261B2 (en) | Lens for vision enhancement | |
JP7357368B2 (en) | Optical device for improving human color vision with improved decorative appearance | |
Artigas et al. | Spectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible light | |
US10912457B2 (en) | Lighting system for simulating conditions of color deficient vision and demonstrating effectiveness of color-blindness compensating eyewear | |
US9820643B2 (en) | Illumination evaluation or recommendation using visual function | |
AU2017444616B2 (en) | Method for measuring optical characteristics of a transparent article | |
TW202223497A (en) | Spectral glare control eyewear for color blindness and low vision assistance | |
CN111712180B (en) | Wearable binocular optoelectronic device for measuring a photosensitivity threshold of a user | |
Fryc et al. | The influence of different photometric observers on luxmeter accuracy for LEDs and FLs lamps measurements | |
Aarnisalo | Effects of yellow filter glasses on the results of photopic and scotopic photometry | |
Jacobs | SynthLight handbook | |
Bailao et al. | Matching colours in pictorial retouching: influence of the three colour dimensions and colour distortion phenomena | |
JP2022039911A (en) | Method for correcting glasses, method for measurement for glass correction, and glasses | |
US20240180419A1 (en) | Method for determining at least one optical product intended to face an eye of a user using an eye resistance level and a light protection level | |
Ikeda et al. | Desaturation of color by environment light in cataract eyes | |
Périssé | Color formulation algorithms improvement through expert knowledge integration for automotive effect paints | |
Wilkins et al. | Coloured filters: clinical tools | |
WO2024170703A1 (en) | Optometry system for determining, for each eye of an individual, a mesopic value of a vision correction power of a corrective lens | |
Guerry et al. | Light and color: a factor of safety in the everyday life of the elderly | |
Radsamrong | Optimized light sources for enhancing color discrimination in people with low vision | |
CN116887746A (en) | Method for determining at least one optical product intended to face the eyes of a user using an eye resistance level and a light protection level | |
Pungrassamee et al. | Failure of color constancy for high luminance of a test patch that appears unnatural as an object in a space | |
Schultz | Illuminating Engineering in Optometry | |
Gloor et al. | Recovery time of the human eye after exposure to extrafoveal monochromatic glare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |